Nattokinase · 270 capsules
Optimal blood flow is important, nothing should stand in the way of this. That's exactly why we launched Gods Rage - Nattokinase: a highly effective enzyme from the traditional Japanese fermentation of natto, reinterpreted as a modern weapon for your circulation, performance and well-being. So what are you waiting for?
- Contains 2,000 FU nattokinase per capsule
- Can improve blood circulation (1)
- May promote natural blood flow & healthy cardiovascular function (1,2,3)
- May reduce the risk of circulatory disorders (1)
- 100% vegan, laboratory tested, without additives
- Highest quality - Made in Germany
Nährwerte und Inhaltsstoffe
| Nutritional value | per capsule |
|---|---|
| Nattokinase 20.000FU/g | 100 mg |
Zutaten: Rice flour, fermented soybean extract (nattokinase 20,000FU/g; Bacillus subtilis Natto). Coating agent: hydroxypropyl methylcellulose (HPMC).
*Prozent der empfohlenen täglichen Verzehrmenge laut Verordnung (EU) Nr. 1196/2011
**Keine Nährstoffbezugswerte (NRV) vorhanden.
Verzehrempfehlung
Hinweise
Manufacturer / Distributor
Gods Rage Europe, London / United Kingdom
Nero Labs BV, Postbus 278, 5900AG Venlo, The Netherlands
Quellen
- Weng Y, Yao J, Sparks S, et al. Nattokinase: An oral antithrombic agent for the prevention of cardiovascular disease. International Journal of Molecular Sciences. 2017;18(3):523. doi:10.3390%2Fijms18030523
- Chen H, McGowan EM, Ren N, et al. Nattokinase: a promising alternative in prevention and treatment of cardiovascular diseases. Biomark Insights. 2018;13:1177271918785130. doi:10.1177/1177271918785130
- Weng Y, Yao J, Sparks S, et al. Nattokinase: An oral antithrombic agent for the prevention of cardiovascular disease. International Journal of Molecular Sciences. 2017;18(3):523. doi:10.3390%2Fijms18030523
- Jensen GS, Lenninger M, Ero MP, et al. Consumption of nattokinase is associated with reduced blood pressure and von Willebrand factor, a cardiovascular risk marker: results from a randomized, double-blind, placebo-controlled, multicenter North American clinical trial. Integrated Blood Pressure Control. 2016;9:95-104. doi:10.2147%2FIBPC.S99553
- Chen H, Chen J, Zhang F, et al. Effective management of atherosclerosis progression and hyperlipidemia with nattokinase: A clinical study with 1,062 participants. Front Cardiovasc Med. 2022;9:964977. doi:10.3389/fcvm.2022.964977
- Jensen GS, Lenninger M, Ero MP, et al. Consumption of nattokinase is associated with reduced blood pressure and von Willebrand factor, a cardiovascular risk marker: results from a randomized, double-blind, placebo-controlled, multicenter North American clinical trial. Integrated Blood Pressure Control. 2016;9:95-104. doi:10.2147%2FIBPC.S99553
Inhalt: 270 capsules Artikelnr.: 8528